• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌的基因组和生物学特征及种族差异

The Genomic and Biologic Landscapes of Breast Cancer and Racial Differences.

作者信息

Galappaththi Sapthala P Loku, Smith Kelly R, Alsatari Enas S, Hunter Rachel, Dyess Donna L, Turbat-Herrera Elba A, Dasgupta Santanu

机构信息

Department of Pathology, Frederick P. Whiddon College of Medicine, University of South Alabama, Mobile, AL 36604, USA.

Mitchell Cancer Institute, University of South Alabama, Mobile, AL 36688, USA.

出版信息

Int J Mol Sci. 2024 Dec 7;25(23):13165. doi: 10.3390/ijms252313165.

DOI:10.3390/ijms252313165
PMID:39684874
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11642636/
Abstract

Breast cancer is a significant health challenge worldwide and is the most frequently diagnosed cancer among women globally. This review provides a comprehensive overview of breast cancer biology, genomics, and microbial dysbiosis, focusing on its various subtypes and racial differences. Breast cancer is primarily classified into carcinomas and sarcomas, with carcinomas constituting most cases. Epidemiology and breast cancer risk factors are important for public health intervention. Staging and grading, based on the TNM and Nottingham grading systems, respectively, are crucial to determining the clinical outcome and treatment decisions. Histopathological subtypes include in situ and invasive carcinomas, such as invasive ductal carcinoma (IDC) and invasive lobular carcinoma (ILC). The review explores molecular subtypes, including Luminal A, Luminal B, Basal-like (Triple Negative), and HER2-enriched, and delves into breast cancer's histological and molecular progression patterns. Recent research findings related to nuclear and mitochondrial genetic alterations, epigenetic reprogramming, and the role of microbiome dysbiosis in breast cancer and racial differences are also reported. The review also provides an update on breast cancer's current diagnostics and treatment modalities.

摘要

乳腺癌是全球一项重大的健康挑战,也是全球女性中最常被诊断出的癌症。本综述全面概述了乳腺癌生物学、基因组学和微生物群落失调,重点关注其各种亚型和种族差异。乳腺癌主要分为癌和肉瘤,其中癌占大多数病例。流行病学和乳腺癌风险因素对公共卫生干预很重要。分别基于TNM和诺丁汉分级系统的分期和分级对于确定临床结果和治疗决策至关重要。组织病理学亚型包括原位癌和浸润性癌,如浸润性导管癌(IDC)和浸润性小叶癌(ILC)。本综述探讨了分子亚型,包括腔面A型、腔面B型、基底样型(三阴性)和HER2富集型,并深入研究了乳腺癌的组织学和分子进展模式。还报告了与核和线粒体基因改变、表观遗传重编程以及微生物群落失调在乳腺癌和种族差异中的作用相关的最新研究结果。本综述还提供了乳腺癌当前诊断和治疗方式的最新信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5fb/11642636/01289bbb74ad/ijms-25-13165-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5fb/11642636/75a3e571a81c/ijms-25-13165-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5fb/11642636/fcac7efba289/ijms-25-13165-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5fb/11642636/d592e7642c21/ijms-25-13165-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5fb/11642636/01289bbb74ad/ijms-25-13165-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5fb/11642636/75a3e571a81c/ijms-25-13165-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5fb/11642636/fcac7efba289/ijms-25-13165-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5fb/11642636/d592e7642c21/ijms-25-13165-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5fb/11642636/01289bbb74ad/ijms-25-13165-g004.jpg

相似文献

1
The Genomic and Biologic Landscapes of Breast Cancer and Racial Differences.乳腺癌的基因组和生物学特征及种族差异
Int J Mol Sci. 2024 Dec 7;25(23):13165. doi: 10.3390/ijms252313165.
2
The prognosis of invasive ductal carcinoma, lobular carcinoma and mixed ductal and lobular carcinoma according to molecular subtypes of the breast.根据乳腺癌的分子亚型,评估浸润性导管癌、小叶癌和混合性导管及小叶癌的预后。
Breast Cancer. 2021 Jan;28(1):187-195. doi: 10.1007/s12282-020-01146-4. Epub 2020 Aug 18.
3
The Current Roadmap of Lung Cancer Biology, Genomics and Racial Disparity.肺癌生物学、基因组学与种族差异的当前路线图
Int J Mol Sci. 2025 Apr 17;26(8):3818. doi: 10.3390/ijms26083818.
4
Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma.管腔型浸润性导管癌与管腔型浸润性小叶癌临床结局的比较。
BMC Cancer. 2016 Mar 25;16:248. doi: 10.1186/s12885-016-2275-4.
5
Nonlobular Invasive Breast Carcinomas with Biallelic Pathogenic CDH1 Somatic Alterations: A Histologic, Immunophenotypic, and Genomic Characterization.具有双等位基因致病性 CDH1 体细胞改变的非小叶状浸润性乳腺癌:组织学、免疫表型和基因组特征。
Mod Pathol. 2024 Feb;37(2):100375. doi: 10.1016/j.modpat.2023.100375. Epub 2023 Nov 3.
6
Strong adverse effect of epidermal growth factor receptor 2 overexpression on prognosis of patients with invasive lobular breast cancer: a comparative study with invasive ductal breast cancer in Chinese population.表皮生长因子受体2过表达对浸润性小叶乳腺癌患者预后的强烈不良影响:一项在中国人群中与浸润性导管癌的对比研究。
Tumour Biol. 2015 Aug;36(8):6113-24. doi: 10.1007/s13277-015-3293-6. Epub 2015 Mar 25.
7
Invasive lobular breast cancer: the prognostic impact of histopathological grade, E-cadherin and molecular subtypes.浸润性小叶乳腺癌:组织病理学分级、E-钙黏蛋白及分子亚型的预后影响
Histopathology. 2015 Feb;66(3):409-19. doi: 10.1111/his.12572. Epub 2014 Dec 22.
8
Transcriptomic and genomic features of invasive lobular breast cancer.浸润性小叶乳腺癌的转录组和基因组特征。
Semin Cancer Biol. 2017 Jun;44:98-105. doi: 10.1016/j.semcancer.2017.03.007. Epub 2017 Apr 8.
9
Analysis of prognosis in different subtypes of invasive lobular carcinoma using the Japanese National Cancer Database-Breast Cancer Registry.利用日本国家癌症数据库-乳腺癌登记处分析不同浸润性小叶癌亚型的预后。
Breast Cancer Res Treat. 2023 Oct;201(3):397-408. doi: 10.1007/s10549-023-07022-x. Epub 2023 Jul 21.
10
Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer.浸润性小叶乳腺癌的综合分子图谱
Cell. 2015 Oct 8;163(2):506-19. doi: 10.1016/j.cell.2015.09.033.

引用本文的文献

1
Triple-Negative Breast Cancer on the Rise: Breakthroughs and Beyond.三阴性乳腺癌发病率上升:突破与未来展望
Breast Cancer (Dove Med Press). 2025 Jun 26;17:523-529. doi: 10.2147/BCTT.S516125. eCollection 2025.
2
Impact of Endocrine Therapy on Osteoporosis Risk in Women with Breast Cancer Across Different Hormonal Stages: A Review.内分泌治疗对不同激素阶段乳腺癌女性骨质疏松风险的影响:一项综述
Curr Oncol. 2025 May 26;32(6):305. doi: 10.3390/curroncol32060305.
3
Replication Factor C Subunit 4 Plays a Role in Human Breast Cancer Cell Progression.

本文引用的文献

1
Immunotherapy in Breast Cancer.乳腺癌的免疫治疗。
Int J Mol Sci. 2024 Jul 9;25(14):7517. doi: 10.3390/ijms25147517.
2
Immunotherapy in breast cancer: A clinician's perspective.乳腺癌免疫治疗:临床医生视角
J Natl Cancer Cent. 2021 Feb 24;1(2):47-57. doi: 10.1016/j.jncc.2021.01.001. eCollection 2021 Jun.
3
Mediterranean diet: Fighting breast cancer naturally: A review.地中海饮食:自然对抗乳腺癌:综述。
复制因子C亚基4在人乳腺癌细胞进展中起作用。
Cancer Genomics Proteomics. 2025 May-Jun;22(3):478-490. doi: 10.21873/cgp.20515.
4
The R-RAS2 GTPase is a signaling hub in triple-negative breast cancer cell metabolism and metastatic behavior.R-RAS2 GTP酶是三阴性乳腺癌细胞代谢和转移行为中的一个信号枢纽。
J Hematol Oncol. 2025 Apr 12;18(1):41. doi: 10.1186/s13045-025-01693-3.
5
Genomic Landscape of Breast Cancer: Study Across Diverse Ethnic Groups.乳腺癌的基因组格局:不同种族群体的研究
Diseases. 2025 Mar 17;13(3):86. doi: 10.3390/diseases13030086.
Medicine (Baltimore). 2024 Jun 28;103(26):e38743. doi: 10.1097/MD.0000000000038743.
4
Specific microbiome patterns and their association with breast cancer: the intestinal microbiota as a potential biomarker and therapeutic strategy.特定微生物群模式及其与乳腺癌的关联:肠道微生物群作为一种潜在的生物标志物和治疗策略。
Clin Transl Oncol. 2025 Jan;27(1):15-41. doi: 10.1007/s12094-024-03554-w. Epub 2024 Jun 18.
5
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
6
Progression from ductal carcinoma in situ to invasive breast cancer: molecular features and clinical significance.从导管原位癌到浸润性乳腺癌的进展:分子特征及临床意义。
Signal Transduct Target Ther. 2024 Apr 3;9(1):83. doi: 10.1038/s41392-024-01779-3.
7
The paradox of MRI for breast cancer screening: high-risk and dense breasts-available evidence and current practice.乳腺癌筛查中MRI的悖论:高危和致密型乳腺——现有证据及当前实践
Insights Imaging. 2024 Mar 27;15(1):96. doi: 10.1186/s13244-024-01653-4.
8
Differences in Histological Subtypes of Invasive Lobular Breast Carcinoma According to Immunohistochemical Molecular Classification.根据免疫组织化学分子分类的浸润性小叶乳腺癌组织学亚型差异
Diagnostics (Basel). 2024 Mar 21;14(6):660. doi: 10.3390/diagnostics14060660.
9
Breast Cancer Molecular Subtyping in Practice: A Real-World Study of the APIS Breast Cancer Subtyping Assay in a Consecutive Series of Breast Core Biopsies.实践中的乳腺癌分子分型:对一系列连续乳腺粗针活检样本进行的APIS乳腺癌分型检测的真实世界研究
Int J Mol Sci. 2024 Feb 23;25(5):2616. doi: 10.3390/ijms25052616.
10
KMT2C and KMT2D aberrations in breast cancer.乳腺癌中 KMT2C 和 KMT2D 的异常。
Trends Cancer. 2024 Jun;10(6):519-530. doi: 10.1016/j.trecan.2024.02.003. Epub 2024 Mar 7.